Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children

Sponsor
Shahid Beheshti University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01118884
Collaborator
(none)
20
1
1
11
1.8

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the safety and efficacy of sedation using orally administered midazolam and promethazine with nitrous oxide/oxygen in uncooperative children receiving dental treatments.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

The effectiveness of oral midazolam in pediatric dentistry is controversial. Usefulness of midazolam alone is limited to short-duration procedures, and we are needed to identify safe oral conscious regiments which permit longer duration procedures in dental treatments especially in Pediatric dentistry.

Promethazine is a long-acting (4-12 hr) anti-histaminic, H1 antagonist drug which acts as a central nervous system depressant and showing itself to be a weak anxiolytic drug.

The hypothesis to be tested is whether promethazine would improve the patients behavior during dental procedures without affecting vital signs, thus enabling longer periods of moderate or conscious sedation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Sedative Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide/Oxygen on Behavior Management of Uncooperative Children Receiving Dental Treatment
Study Start Date :
Jun 1, 2009
Anticipated Primary Completion Date :
Apr 1, 2010
Anticipated Study Completion Date :
May 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: sedation

20 healthy uncooperative children aged 36-96 months were examined in a cross-over study design , each patient served as his/her own control. Each patient was assigned randomly to received 1 of 2 drug regimens for initial sedation session and the other regimen administered at second session which was one week later.

Drug: Promethazine
Syrup ,1 mg/kg, oral , 30 minutes before dental procedure , its duration is 4-6 hours
Other Names:
  • Phenergan
  • Prothiazine
  • Promethegan
  • Romergan
  • Outcome Measures

    Primary Outcome Measures

    1. Behavior change [during dental treatment which is 30 minutes after drug ingestion]

      Behavior evaluation was based on a scale proposed by Houpt et al. which establishes the following scores : sleep, movement, crying , overall behavior.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    36 Months to 96 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy patients who are in ASA class 1 group

    • Age of the patients must be between 36-96 months

    • Uncooperative children who are in groups 1 or 2 according to Frankel's classification

    Exclusion Criteria:
    • Tonsil hypertrophy

    • History of allergies

    • Drooling or nocturnal snoring

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dental school of Shahid Beheshti University of Medical Sciences Tehran Iran, Islamic Republic of 19839

    Sponsors and Collaborators

    • Shahid Beheshti University

    Investigators

    • Principal Investigator: Sedighe Mozaffar, Postgraduate student of Shahid Beheshti Medicine University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01118884
    Other Study ID Numbers:
    • 171598
    First Posted:
    May 7, 2010
    Last Update Posted:
    May 7, 2010
    Last Verified:
    Apr 1, 2010
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 7, 2010